CN1383847A - Chinese medicine composition for treating sequelae for cerebral infraction - Google Patents
Chinese medicine composition for treating sequelae for cerebral infraction Download PDFInfo
- Publication number
- CN1383847A CN1383847A CN 01117635 CN01117635A CN1383847A CN 1383847 A CN1383847 A CN 1383847A CN 01117635 CN01117635 CN 01117635 CN 01117635 A CN01117635 A CN 01117635A CN 1383847 A CN1383847 A CN 1383847A
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine composition
- chinese medicine
- blood
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to one kind of Chinese medicine composition for treating protrusion of lumber interverterbal disc. It has special recipe developed based on the treating method of invigorating liver and kidney, benefiting vital energy and blood and stopping Bi pain and is prepared into capsule filled with fine medicine powder. The present invention is an organic combination of Chinese medical theory and practice and the medicine has reliable curative effect and no toxic side effect.
Description
The present invention relates to a kind of Chinese medicine composition for the treatment of cerebral infarction.During modern times were clinical, the brain jam day for human beings was cumulative many, and modern medicine treatment primary disease adopts blood vessel dilating more, microcirculation improvement, and nourishing brain cell, dehydrations etc. have definite curative effect to patients during acute stage, but relatively poor to curative effects such as sequela such as hemiplegias.Motherland's therapeutic treatment cerebral infarction sequela, according to old weakness of QI, in conjunction with the objective knowledge of modern medicine to primary disease, as there is high blood viscosity etc. in the theory of blood stasis due to qi deficiency, thinks that " blood stasis due to qi deficiency " is the main pathogenesis of sequela." benefiting QI for activating blood circulation, blood nourishing acupuncture-stimulating " is the main rule of treatment of primary disease, and said composition is exactly the specific prescription for certain illness of developing on this basis.
The present invention is achieved in that the composition percentage by weight of invention medicine is: the Radix Astragali 21%, Radix Paeoniae Rubra 9%, Radix Angelicae Sinensis 11%, Pheretima 6.5%, Rhizoma Chuanxiong 13%, uncommon Herba Siegesbeckiae 11%, Semen Persicae 11%, Flos Carthami 11%, Radix Glycyrrhizae 6%, Hirudo 6.5%.
Preparation: grind to the powder altogether, make capsule, every heavily about 0.45g of pastille with capsule filler.
Cure mainly: the benefiting QI for activating blood circulation collateral dredging cures mainly apoplexy sequela---hemiplegia.
Usage: each 5, every day 3 times, 1 month is a course of treatment.
Points for attention: regulate feelings will during the medication, strengthen rehabilitation training.
Medicine of the present invention at the dialectical genus blood stasis due to qi deficiency of cerebral infarction sequela patient.Motherland's medical science thinks that the cerebral infarction patient is old for many years, the deficiency of vital energy, and the capable then blood of gas is capable, and the deficiency of vital energy is blood stasis then, and blood stasis must stop, and passages through which vital energy circulates is obstructed, so hemiplegia occurs.The benefiting QI for activating blood circulation collateral dredging is answered in treatment.Radix Astragali master is a principal agent with big invigorating middle warmer gas in the side; Chinese Angelica blood replonishing is invigorated blood circulation, Radix Paeoniae Rubra, river waist; The Ramulus Cinnamomi warming YANG to expel cold, the Radix Clematidis expelling wind and dampness is for controlling the key medicine of arthromyodynia; Semen Coicis, Radix Saposhnikoviae invigorating spleen to remove dampness, Rhizoma Chuanxiong capable " gas in the blood, the blood in the lively atmosphere " is good at walking to make the final alterations pain, for drawing the priming sick institute that goes directly, the merit of the cold expelling of invigorating blood circulation is arranged with yellow wine.All medicines share to play altogether and fill blood, strengthening bone and muscle, and expelling wind and cold, dehumidifying is invigorated blood circulation, the effect of stimulating menstrual flow and reducing pain.
Medicine of the present invention has following advantage:
1. theory of Chinese medical science combines with practice.
2. curative effect is reliable, nontoxic pair of effect.Through the systematic observation to 60 these diseases of example, clinical effective rate reaches 90.8%.
3. convenient and practical.This prescription material source is abundant, draws materials conveniently, and dosage form is made does not need special installation.
Embodiment 1: be used for the prolapse of lumbar intervertebral disc patient, patient's waist company and right lower extremity pain, numb half a year, increased the weight of limitation of activity 1 month, the light red tongue white and thin fur, deep and tense pulse, there is tenderness on the L4/5 side, right lower extremity straight-leg raising test (+), large levies (+), and lumbar intervertebral disc CT shows that the L4/5 intercalated disc deviates from.Its drug regimen percentage ratio is as follows: Radix Astragali 18g, Radix Paeoniae Alba 15g, Ramulus Cinnamomi 15g, Radix Angelicae Sinensis 15g, Rhizoma Chuanxiong 18g, Radix Achyranthis Bidentatae 15g, Radix Clematidis 18g, Cortex Eucommiae 15g, Semen Coicis 15g, Radix Saposhnikoviae 15g, Radix Glycyrrhizae 9g.
Embodiment 2: be used for the lumbar intervertebral disc protrusion people, left limb pain half a year appears in patient repeatedly, and light during rest, heavy when movable, pale tongue with thin fur is white, stringy and rolling pulse.Left lower extremity straight-leg raising test (+) is strengthened test (+), and the lumbar X mating plate shows that the L4/5 intercalated disc is outstanding.Its medicament composing prescription percentage ratio is: Radix Astragali 18g, Radix Paeoniae Alba 15g, Ramulus Cinnamomi 15g, Radix Angelicae Sinensis 15g, Rhizoma Chuanxiong 18g, Radix Achyranthis Bidentatae 15g, Radix Clematidis 18g, Cortex Eucommiae 15g, Semen Coicis 15g, Radix Saposhnikoviae 15g, Radix Glycyrrhizae 9g.
Embodiment 3: be used for the lumbar intervertebral disc protrusion people.Patient's lumbago 15 days, emit to the right lower extremity shank outside during pain outbreak, limitation of activity, light red tongue purple, white and thin fur, stringy and rolling pulse, right lower extremity straight-leg raising test (+), strengthen test (+), its medicament composing prescription is as follows: Radix Astragali 18g, Radix Paeoniae Alba 15g, Ramulus Cinnamomi 15g, Radix Angelicae Sinensis 15g, Rhizoma Chuanxiong 18g, Radix Achyranthis Bidentatae 15g, Radix Clematidis 18g, Cortex Eucommiae 15g, Semen Coicis 15g, Radix Saposhnikoviae 15g, Radix Glycyrrhizae 9g.
Claims (2)
1. special side who treats prolapse of lumbar intervertebral disc comprises that distinctive clinical dialectical executing control, and is characterised in that percentage by weight is formed and formed to special side's medicine.
2. the Chinese medicine composition of deviating from according to the described treatment lumbar intervertebral disc of claim is characterized in that compositions processing mode, dosage form and consumption.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 01117635 CN1383847A (en) | 2001-04-30 | 2001-04-30 | Chinese medicine composition for treating sequelae for cerebral infraction |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 01117635 CN1383847A (en) | 2001-04-30 | 2001-04-30 | Chinese medicine composition for treating sequelae for cerebral infraction |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1383847A true CN1383847A (en) | 2002-12-11 |
Family
ID=4662812
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 01117635 Pending CN1383847A (en) | 2001-04-30 | 2001-04-30 | Chinese medicine composition for treating sequelae for cerebral infraction |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1383847A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114869956A (en) * | 2022-02-11 | 2022-08-09 | 福建中医药大学附属人民医院(福建省人民医院) | Pharmaceutical composition for treating post-stroke motor dysfunction and preparation method and application thereof |
-
2001
- 2001-04-30 CN CN 01117635 patent/CN1383847A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114869956A (en) * | 2022-02-11 | 2022-08-09 | 福建中医药大学附属人民医院(福建省人民医院) | Pharmaceutical composition for treating post-stroke motor dysfunction and preparation method and application thereof |
CN114869956B (en) * | 2022-02-11 | 2023-09-22 | 福建中医药大学附属人民医院(福建省人民医院) | Pharmaceutical composition for treating post-stroke dyskinesia, and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100548350C (en) | A kind of Chinese medicine for the treatment of thromboangiitis obliterans | |
CN102872442B (en) | Traditional Chinese medicine capsule for treating scapulohumeral periarthritis | |
CN101167817B (en) | Traditional Chinese medicine for treating migraine | |
CN100376229C (en) | A medicinal wine for treating rheumatic and rheumatoid disease | |
CN103784570A (en) | Chinese herbal preparation for treating neonatal jaundice | |
CN101905006B (en) | External medicament for treating traumatic injury | |
CN1257715A (en) | Tincture for treating rheumatoid arthritis and its preparing process | |
CN104547666A (en) | Traditional Chinese medicine composition for treating herpes zoster | |
CN106139110A (en) | A kind of Chinese medicine composition for treating varicose veins of the lower extremity | |
CN106039245A (en) | External traditional Chinese medicine mineral spring mud for treating rheumatoid bone diseases and preparation method thereof | |
CN103393862A (en) | Chinese medicinal composition for treating lumbocrural pain | |
CN108785578A (en) | A kind of topical agent for treating pelvic inflammatory disease | |
CN102846903A (en) | Traditional Chinese medicinal preparation for treating chronic pyelonephritis | |
CN101721651B (en) | Traditional Chinese medicine capsule for treating scapulohumeral periarthritis | |
CN105749207A (en) | Traditional Chinese medicine composition for expelling wind and removing cold | |
CN100411648C (en) | Medicine for treating atrophic arthritis | |
CN103830672A (en) | Traditional Chinese medicine for treating scapulohumeral periarthritis | |
CN101129425B (en) | Traditional Chinese medicine for treating zoster | |
CN1324650A (en) | Effective medicine for treating cervical vertebra disease as one kind of intractable disease | |
CN1383847A (en) | Chinese medicine composition for treating sequelae for cerebral infraction | |
CN101596297B (en) | Tinea-curing pill | |
CN101085303A (en) | Oral administration traditional Chinese medicine composition for treating hyperplasia of mammary glands | |
CN1160102C (en) | Chinese medicine for curing female chronic inflammation | |
CN1132096A (en) | Chinese drug for treatment of hemiplegia | |
CN100411645C (en) | Hyperosteogeny treating medicine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |